Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001493152-24-034898
Filing Date
2024-09-04
Accepted
2024-09-03 21:51:36
Documents
87
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 form10-ka.htm   iXBRL 10-K/A 2889980
2 ex21.htm EX-21 2394
3 ex23-1.htm EX-23.1 3699
4 ex31-1.htm EX-31.1 11753
5 ex31-2.htm EX-31.2 12419
6 ex32-1.htm EX-32.1 6784
7 ex32-2.htm EX-32.2 6904
8 form10-k_001.jpg GRAPHIC 27071
9 form10-k_002.jpg GRAPHIC 106726
10 form10-k_003.jpg GRAPHIC 20538
11 form10-k_004.jpg GRAPHIC 20085
12 form10-k_005.jpg GRAPHIC 155967
  Complete submission text file 0001493152-24-034898.txt   13121215

Data Files

Seq Description Document Type Size
13 XBRL SCHEMA FILE shph-20231231.xsd EX-101.SCH 76094
14 XBRL CALCULATION FILE shph-20231231_cal.xml EX-101.CAL 79308
15 XBRL DEFINITION FILE shph-20231231_def.xml EX-101.DEF 419505
16 XBRL LABEL FILE shph-20231231_lab.xml EX-101.LAB 614024
17 XBRL PRESENTATION FILE shph-20231231_pre.xml EX-101.PRE 519809
90 EXTRACTED XBRL INSTANCE DOCUMENT form10-ka_htm.xml XML 2041909
Mailing Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879
Business Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879 (240) 403-4212
Shuttle Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001757499 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-41488 | Film No.: 241275758
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)